Busquets, J. http://orcid.org/0000-0001-6685-3135
Martín, S. http://orcid.org/0000-0002-1914-195X
Secanella, Ll. http://orcid.org/0000-0002-8512-0364
Sorribas, M. http://orcid.org/0000-0003-2354-3860
Cornellà, N.
Altet, J.
Peláez, N.
Bajen, M.
Carnaval, T. http://orcid.org/0000-0003-3353-5186
Videla, S. http://orcid.org/0000-0001-5049-1379
Fabregat, J.
Funding for this research was provided by:
Universitat de Barcelona
Article History
Received: 13 July 2021
Accepted: 4 June 2022
First Online: 4 July 2022
Declarations
:
: The study protocol was approved by the Ethics Committee (185/03) of the Bellvitge University Hospital, University of Barcelona, and it was registered at ClinicalTrials.gov (QUANUPAD Trial; NCT03984734). The study complied with the criteria set by the Declaration of Helsinki (revised on WMA 64<sup>th</sup> General Assembly, Fortaleza, Brazil, October 2013), Good Clinical Practice (GCP) standards, and applicable regulations.
: Written informed consent was obtained from all the patients included.
: The authors declare no competing interests.